For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

The study is part of a growing body of research examining the benefits of climate change solutions on human health.

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

People using beclometasone inhalers for asthma or other health conditions may want to read up on the NHS guidance for the ...

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

A recent study revealed that popular GLP-1 weight-loss drugs may significantly minimise severe asthma attacks among teenagers ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...